Risk assessment in relatives of gastric cancer patients: Hyperproliferation, genetics, and Helicobacter pylori infection

European Journal of Gastroenterology and Hepatology

Volumn 18, Issue 8, 2006, Pages 877-879

  Ignasi Elizalde, J ^a   Piqué, Josep M ^a,b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

Family history; Gastric cancer; Genetics; Helicobacter pylori

Indexed keywords

BACTERIAL INFECTION; CANCER PATIENT; CANCER RISK; FAMILY; GENETIC COUNSELING; GENETIC DISORDER; HELICOBACTER PYLORI; HISTOLOGY; HUMAN; NONHUMAN; PRIORITY JOURNAL; RELATIVE; RISK ASSESSMENT; SHORT SURVEY; STOMACH CANCER;

FAMILY; GASTRIC MUCOSA; GENETIC PREDISPOSITION TO DISEASE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; RISK ASSESSMENT; RISK FACTORS; STOMACH NEOPLASMS;

EID: 33745816363     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-200608000-00013     Document Type: Short Survey

References (40)

1. Globocan 2002. International Agency for Research in Cancer. Available at: http://www-dep.iarc.fr/. Accessed: October 2005.
2. Kountouras J, Zavos C, Chatzopoulos D. New concepts of molecular biology on gastric carcinogenesis. Hepatogastroenterology 2005; 52:1305-1312.
3. Palli D, Galli M, Caporaso NE, Cipriani F, Decarli A, Saieva C, et al. Family history and risk of stomach cancer in Italy. Cancer Epidemiol Biomark Prev 1994; 3:15-18.
4. Guilford P, Hopkins J, Harraway J, McLeod M, McLeod N, Harawira P, et al. E-cadherin germline mutations in familial gastric cancer. Nature 1998; 392:402-405.
5. Caldas C, Carneiro F, Lynch HT, Yokota J, Wiesner GL, Powell SM, et al. Familial gastric cancer: overview and guidelines for management. J Med Genet 1999; 36:873-880.
6. Lynch HT, Grady W, Suriano G, Huntsman D. Gastric cancer: new genetic developments. J Surg Oncol 2005; 90:114-133.
7. Biedermann K, Vogelsang H, Becker I, Plaschke S, Siewert JR, Hofler H, Keller G. Desmoglein-2 is expressed abnormally rather than mutated in familial and sporadic gastric cancer. J Pathol 2005; 207:199-206.
8. Li JH, Shi XZ, Lu S, Liu M, Cui WM, Liu LN, et al. HMLH1 gene mutation in gastric cancer patients and their kindred. World J Gastroenterol 2005; 11:3144-3146.
9. Rocco A, Staibano S, Ottini L, Mezza E, Somma P, Mariani-Costantini R, ef al. Is there a link between environmental factors and a genetic predisposition to cancer? A lesson from a familial cluster of gastric cancers. Eur J Cancer 2003; 39:1619-1624.
10. Yu J, Miehlke S, Ebert M, Szokodi D, Wehvnignh B, Malfertheiner P, et al. Expression of cyclin genes in human gastric cancer and in first degree relatives. Chin Med J 2002; 115:710-715.
11. Sheu BS, Yang HB, Sheu SM, Huang AH, Wu JJ. Higher gastric cyclooxygenase-2 expression and precancerous change in Helicobacter pylori-infected relatives of gastric cancer patients. Clin Cancer Res 2003; 9:5245-5251.
12. Zhang JT, Wang MW, Zhu ZL, Huo XH, Chu JK, Cui DS, et al. Increased expression of cyclooxygenase-2 in first degree relatives of gastric cancer patients. World J Gastroenterol 2005; 11:4918-4922.
13. Yu J, Ebert MPA, Miehlke S, Rost H, Lendeckel U, Leodolter A, et al. α-Catenin expression is decreased in human gastric cancers and in the gastric mucosa of first-degree relatives. Gut 2000; 46:639-644.
14. Di Mario F, Moussa AM, Caruana P, Merli R, Cavallaro LG, Cavestro GM, et al. Serological biopsy in first-degree relatives of patients with gastric cancer affected by Helicobacter pylori infection. Scand J Gastroenterol 2003; 28:1223-1227.
15. El-Omar E, Oien K, Murray LS, El-Nujumi A, Wirz A, Gillen D, et al. Increased prevalence of precancerous changes in relatives of gastric cancer patients: critical role of H. pylori. Gastroenterology 2000; 118:22-30.
16. Brenner H, Bode G, Boeing H. Helicobacter pylori infection among offspring of patients with stomach cancer. Gastroenterology 2000; 118:31-35.
17. Chang YW, Han YS, Lee DK, Kim HJ, Lim HS, Moon JS, et al. Role of Helicobacter pylori infection among offspring or siblings of gastric cancer patients. Int J Cancer 2002; 101:469-474.
18. Brenner H, Arndt V, Sturmer T, Stegmaier C, Ziegler H, Dhom G. Individual and joint contribution of family history and Helicobacter pylori infection to the risk of gastric carcinoma. Cancer 2000; 88:274-279.
19. Meining A, Hackelsberger A, Daenecke C, Stolte M, Beyerdorffer E, Ochsenkuhn T. Increased cell proliferation of the gastric mucosa in first-degree relatives of gastric carcinoma patients. Cancer 1998; 83: 876-881.
20. Zullo A, Hassan C, Marangi S, Burattini O, Romiti A, De Francesco V, et al. Gastric epithelial cell proliferation and ras oncogene p21 expression in first-degree relatives of gastric cancer patients: a case-control study. Eur J Gastroenterol Hepatol 2006; 18:921-926.
21. The Eurogast Study Group. Epidemiology and risk factors for Helicobacter pylori infection among 3194 asymptomatic subjects in 17 populations. Gut 1993; 34:1672-1676.
22. Parsonnet J, Friedman GD, Vandersteen DP, Chang Y, Vogelman JH, Orentreich N, Sibley RK. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991; 325:1127-1131.
23. Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, et al. Helicobacter pylori and the development of gastric cancer. N Engl J Med 2001; 345:784-789.
24. Watanabe T, Tada M, Nagai H, Sasaki S, Nakao M. Helicobacter pylori infection induces gastric cancer in Mongolian gerbils. Gastroenterology 1998; 115:642-648.
25. Caix X, Carlsson J, Stoicov C, Wang TC, Houghton J. Helicobacter felis eradication restores normal architecture and inhibits gastric cancer progression in C57BL/6 mice. Gastroenterology 2005; 128:1937-1952.
26. Correa P, Fontham E, Bravo JC, Bravo LE, Ruiz B, Zarama G, et al. Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-Helicobacter pylori therapy. J Natl Cancer Inst 2000; 92:1881-1888.
27. Ley C, Mohar P, Guarner J, Herrera-Goepfert R, Figueroa LS, Halperin D, et al. Helicobacter pylori eradication and gastric preneoplastic conditions: a randomized, double blind, placebo-controlled trial. Cancer Epidemiol Biomark Prev 2004; 13:4-10.
28. Leung WK, Lin SR, Ching JYL, To KF, Ng EK, Chan FK, et al. Factors predicting progression of gastric intestinal metaplasia: results of a randomised trial on Helicobacter pylori eradication. Gut 2004; 53: 1244-1249.
29. Wong BCY, Lam S, Wong WM, Chen JS, Zheng TT, Feng RE, et al. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China. A randomized controlled trial. JAMA 2004; 291:187-194.
30. Yokota T, Kunii Y, Teshima S, Yamada Y, Saito T, Takahashi M, et al. Significant prognostic factors in patients with early gastric cancer. Int Surg 2000; 85:286-290.
31. Fendrick AM, Chernew ME, Hirth RA, Bloom BS, Bandekar RR, Scheiman JM. Clinical and economic effects of population-based Helicobacter pylori screening to prevent gastric cancer. Arch Intern Med 1999; 159:142-148.
32. Watabe H, Mitsushima T, Yamaji Y, Okamoto M, Wada R, Kokubo T, et al. Predicting the development of gastric cancer from combining Helicobacter pylori antibodies and serum pepsinogen status: a prospective endoscopic cohort study. Gut 2005; 54:764-768.
33. Azuma T, Yamakawa A, Yamazaki S, Fukuta K, Ohtani M, Ito Y, et al. Correlation between variation of the 3′ region of the cagA gene in Helicobacter pylori and disease outcome in Japan. J Infect Dis 2002; 186:1621-1630.
34. Argent RH, Kidd M, Owen RJ, Thomas RJ, Limb MC, Atherton JC. Determinants and consequences of different levels of CagA phosphorylation for clinical isolates of Helicobacter pylori. Gastroenterology 2004; 127:514-523.
35. Machado JC, Figueiredo C, Canedo P, Pharoah P, Carvalho R, Nabais S, et al. A proinflammatory genetic profile increases the risk for chronic atrophic gastritis and gastric carcinoma. Gastroenterology 2003; 125:364-371.
36. El-Omar EM, Rabkin CS, Gammon MD, Vaughan TL, Risch HA, Schoenberg JB, et al. Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroenterology 2003; 124:1193-1201.
37. Quintero E, Pizarro MA, Rodrigo L, Pique JM, Lanas A, Ponce J, et al. Association of Helicobacter pylori-related distal gastric cancer with the HLA class II gene DQB10602 and cagA strains in a southern European population. Helicobacter 2005; 10:12-21.
38. Malfertheiner P, Megraud F, O'Morain C, Hungin AP, Jones R, Axon A, et al. Current concepts in the management of Helicobacter pylori infection. The Maastrich 2-2000 consensus report. Aliment Pharmacol Ther 2002; 16:167-180.
39. Yasui W, Oue N, Aung PP, Matsumura S, Shutoh M, Nakayama H. Molecular-pathological prognostic factors of gastric cancer: a review. Gastric Cancer 2005; 8:86-94.
40. Kim TY, Jong HA, Jung Y, Kim TY, Kang GH. DNA hypermethylation in gastric cancer. Aliment Pharmacol Ther 2004; 20 (suppl 1):131-142.